Trucept Stock Net Income
| TREP Stock | USD 0.02 0 17.74% |
As of the 26th of January, Trucept has the Coefficient Of Variation of 1819.72, risk adjusted performance of 0.0497, and Semi Deviation of 9.62. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Trucept, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Trucept's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Trucept's valuation are summarized below:Trucept does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Trucept |
Trucept 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Trucept's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Trucept.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Trucept on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Trucept or generate 0.0% return on investment in Trucept over 90 days. Trucept is related to or competes with Ozop Surgical, and Orion Diversified. Trucept, Inc., through its subsidiaries, provides business services in the United States More
Trucept Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Trucept's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Trucept upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 16.23 | |||
| Information Ratio | 0.0491 | |||
| Maximum Drawdown | 78.63 | |||
| Value At Risk | (22.11) | |||
| Potential Upside | 29.03 |
Trucept Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trucept's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Trucept's standard deviation. In reality, there are many statistical measures that can use Trucept historical prices to predict the future Trucept's volatility.| Risk Adjusted Performance | 0.0497 | |||
| Jensen Alpha | 0.7998 | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | 0.0406 | |||
| Treynor Ratio | (0.68) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Trucept's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trucept January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0497 | |||
| Market Risk Adjusted Performance | (0.67) | |||
| Mean Deviation | 7.87 | |||
| Semi Deviation | 9.62 | |||
| Downside Deviation | 16.23 | |||
| Coefficient Of Variation | 1819.72 | |||
| Standard Deviation | 13.42 | |||
| Variance | 179.97 | |||
| Information Ratio | 0.0491 | |||
| Jensen Alpha | 0.7998 | |||
| Total Risk Alpha | (0.53) | |||
| Sortino Ratio | 0.0406 | |||
| Treynor Ratio | (0.68) | |||
| Maximum Drawdown | 78.63 | |||
| Value At Risk | (22.11) | |||
| Potential Upside | 29.03 | |||
| Downside Variance | 263.31 | |||
| Semi Variance | 92.51 | |||
| Expected Short fall | (15.16) | |||
| Skewness | 0.7333 | |||
| Kurtosis | 3.05 |
Trucept Backtested Returns
Trucept appears to be out of control, given 3 months investment horizon. Trucept owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0508, which indicates the firm had a 0.0508 % return per unit of risk over the last 3 months. By inspecting Trucept's technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please review Trucept's Semi Deviation of 9.62, coefficient of variation of 1819.72, and Risk Adjusted Performance of 0.0497 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Trucept holds a performance score of 4. The entity has a beta of -1.06, which indicates a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Trucept are expected to decrease slowly. On the other hand, during market turmoil, Trucept is expected to outperform it slightly. Please check Trucept's downside variance, as well as the relationship between the rate of daily change and relative strength index , to make a quick decision on whether Trucept's existing price patterns will revert.
Auto-correlation | -0.46 |
Modest reverse predictability
Trucept has modest reverse predictability. Overlapping area represents the amount of predictability between Trucept time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Trucept price movement. The serial correlation of -0.46 indicates that about 46.0% of current Trucept price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Trucept reported net income of 1.65 M. This is 99.37% lower than that of the Industrials sector and significantly higher than that of the Staffing & Employment Services industry. The net income for all United States stocks is 99.71% higher than that of the company.
Trucept Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trucept's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Trucept could also be used in its relative valuation, which is a method of valuing Trucept by comparing valuation metrics of similar companies.Trucept is currently under evaluation in net income category among its peers.
Trucept Fundamentals
| Return On Equity | 0.0036 | |||
| Return On Asset | -0.006 | |||
| Profit Margin | 0 % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 221.15 K | |||
| Shares Outstanding | 50.26 M | |||
| Price To Earning | (0.05) X | |||
| Price To Sales | 0.10 X | |||
| Revenue | 20 M | |||
| Gross Profit | 9.31 M | |||
| EBITDA | (7.28 M) | |||
| Net Income | 1.65 M | |||
| Cash And Equivalents | 78.09 K | |||
| Total Debt | 1.13 M | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | 0.32 X | |||
| Cash Flow From Operations | 2.44 M | |||
| Earnings Per Share | (0.16) X | |||
| Beta | -6.29 | |||
| Market Capitalization | 2.77 M | |||
| Total Asset | 18.96 M | |||
| Retained Earnings | (21.58 M) | |||
| Working Capital | (28.33 M) | |||
| Current Asset | 4.89 M | |||
| Current Liabilities | 33.22 M | |||
| Z Score | -0.4 |
About Trucept Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trucept's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trucept using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trucept based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Trucept
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Trucept position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trucept will appreciate offsetting losses from the drop in the long position's value.Moving against Trucept Pink Sheet
The ability to find closely correlated positions to Trucept could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Trucept when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Trucept - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Trucept to buy it.
The correlation of Trucept is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Trucept moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Trucept moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Trucept can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Trucept Pink Sheet Analysis
When running Trucept's price analysis, check to measure Trucept's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trucept is operating at the current time. Most of Trucept's value examination focuses on studying past and present price action to predict the probability of Trucept's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trucept's price. Additionally, you may evaluate how the addition of Trucept to your portfolios can decrease your overall portfolio volatility.